S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi

R1 RCM (RCM) Stock Price, News & Analysis

$11.10
-0.04 (-0.36%)
(As of 02/23/2024 ET)
Today's Range
$10.98
$11.26
50-Day Range
$9.11
$11.17
52-Week Range
$8.87
$18.70
Volume
6.90 million shs
Average Volume
2.68 million shs
Market Capitalization
$4.65 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00

R1 RCM MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.92 Rating Score
Upside/​Downside
62.2% Upside
$18.00 Price Target
Short Interest
Bearish
14.28% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.33
Upright™ Environmental Score
News Sentiment
0.59mentions of R1 RCM in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
250.00%
From $0.02 to $0.07 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.81 out of 5 stars

Business Services Sector

11th out of 308 stocks

Management Services Industry

1st out of 5 stocks


RCM stock logo

About R1 RCM Stock (NASDAQ:RCM)

R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. R1 RCM Inc. was founded in 2003 and is headquartered in Murray, Utah.

RCM Stock Price History

RCM Stock News Headlines

R1 RCM (RCM) Scheduled to Post Earnings on Tuesday
Has the Fed lost control of the banking system?
The 24-year market veteran who's been profiled in Barron's and Bloomberg is now warning that the Federal Reserve has completely lost control of the banking system. Millions of Americans could be caught off guard when they try to get their money out of the bank on March 11.
R1 RCM to Present at Upcoming Investor Conferences
TIXT vs. RCM: Which Stock Is the Better Value Option?
The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
R1 RCM stock just surged on these hot analyst comments
Stocks to Watch: Discover Financial, LiveRamp, R1 RCM
R1 RCM Announces Preliminary Fourth Quarter Results
What 10 Analyst Ratings Have To Say About R1 RCM
Morgan Stanley Upgrades R1 RCM (RCM)
JP Morgan Downgrades R1 RCM (RCM)
R1 RCM to Buy Acclara For $675 Million, Warrants
See More Headlines
Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/16/2023
Today
2/24/2024
Next Earnings (Confirmed)
2/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:RCM
CUSIP
00438V10
Employees
27,800
Year Founded
2003

Price Target and Rating

Average Stock Price Target
$18.00
High Stock Price Target
$22.00
Low Stock Price Target
$11.00
Potential Upside/Downside
+62.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.92
Research Coverage
13 Analysts

Profitability

Net Income
$-63,300,000.00
Pretax Margin
-1.31%

Debt

Sales & Book Value

Annual Sales
$2.21 billion
Cash Flow
$0.28 per share
Book Value
$6.49 per share

Miscellaneous

Free Float
264,164,000
Market Cap
$4.65 billion
Optionable
Optionable
Beta
0.74

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report














RCM Stock Analysis - Frequently Asked Questions

Should I buy or sell R1 RCM stock right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 1 hold rating and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" RCM shares.
View RCM analyst ratings
or view top-rated stocks.

What is R1 RCM's stock price target for 2024?

13 Wall Street analysts have issued 12 month target prices for R1 RCM's shares. Their RCM share price targets range from $11.00 to $22.00. On average, they anticipate the company's share price to reach $18.00 in the next year. This suggests a possible upside of 62.2% from the stock's current price.
View analysts price targets for RCM
or view top-rated stocks among Wall Street analysts.

How have RCM shares performed in 2024?

R1 RCM's stock was trading at $10.57 on January 1st, 2024. Since then, RCM stock has increased by 5.0% and is now trading at $11.10.
View the best growth stocks for 2024 here
.

Are investors shorting R1 RCM?

R1 RCM saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 27,500,000 shares, an increase of 11.6% from the January 15th total of 24,640,000 shares. Based on an average daily trading volume, of 3,870,000 shares, the short-interest ratio is presently 7.1 days. Approximately 14.3% of the company's stock are short sold.
View R1 RCM's Short Interest
.

When is R1 RCM's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our RCM earnings forecast
.

How can I listen to R1 RCM's earnings call?

R1 RCM will be holding an earnings conference call on Tuesday, February 27th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were R1 RCM's earnings last quarter?

R1 RCM Inc. (NASDAQ:RCM) issued its quarterly earnings data on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.03) by $0.06. The healthcare provider earned $532.80 million during the quarter, compared to analyst estimates of $519.28 million. R1 RCM had a negative net margin of 1.59% and a negative trailing twelve-month return on equity of 1.29%. The company's revenue was up 33.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.11 earnings per share.

What guidance has R1 RCM issued on next quarter's earnings?

R1 RCM updated its fourth quarter 2023 earnings guidance on Monday, January, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $563.0 million-$567.0 million, compared to the consensus revenue estimate of $586.6 million.

What is Joseph Flanagan's approval rating as R1 RCM's CEO?

253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees.

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN).

Who are R1 RCM's major shareholders?

R1 RCM's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (3.62%), Capital International Investors (1.99%), Voss Capital LLC (1.70%), Norges Bank (0.96%), P2 Capital Partners LLC (0.84%) and Dimensional Fund Advisors LP (0.67%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl, Gary Steven Long, John B Henneman III, John M Sparby, Joseph Gerard Flanagan, Lee Rivas and Richard B Jr Evans.
View institutional ownership trends
.

How do I buy shares of R1 RCM?

Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does R1 RCM have any subsidiaries?
The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.
Read More
This page (NASDAQ:RCM) was last updated on 2/25/2024 by MarketBeat.com Staff